Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Biomarker discovery Driving technologies" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Biomarker discovery Driving technologies for you to read. Along with our medical data and news we also list Biomarker discovery Driving technologies Clinical Trials, which are updated daily. BioPortfolio also has a large database of Biomarker discovery Driving technologies Companies for you to search.
Stemina Biomarker Discovery Inc. today announced the launch of the largest clinical study of the metabolism of children with autism spectrum disorder (ASD) ever conducted.Read more about Stemina Biomarker Discovery Launches Largest Ever Clinical Stud...
Predictive biomarkers are invaluable for successful and cost-effective treatment of cancer, however, biomarker discovery is difficult and requires multiple independent studies to identify suitable predictors of efficacy. Clinical trials performed in ...
The summit will address the latest developments in the biomarker arena from discovery to translation to commercialization. Presentations span across multiple disciplines and cover topics such as discovery and validation strategies, the challenges of ...
Researchers may have found a biomarker for episodic migraine in the blood, a discovery that could have implications for the diagnosis and treatment of the condition.
To date, no biomarker has been found for lung cancer. This discovery could help quick and cost-effective diagnosis at an earlier stage of the disease, improving survival rates.
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers from Queen Mary University of London have found. The discovery could lead to a non-invasive, inexpensive test to screen people at high risk of developing the disease.Read more
Researchers have discovered a blood biomarker that is 'highly effective' in distinguishing between people with and without nonsmall cell lung cancer.
Scientists part-funded by Breast Cancer Now, Human Genetics Foundation (HuGeF), and the Cancer Council Victoria (Melbourne, Australia) have identified a new biomarker in the blood that could help identify more women at an increased risk of breast can...
Researchers at the Johns Hopkins University School of Medicine may have found a new blood biomarker for episodic migraines, according to recent research. Read more about Potential New Biomarker for MigrainesComments
Berg, a Boston biotech, has a strong artificial intelligence platform for drug discovery. It has several drugs in its pipeline, and is leading an effort to discover the very first biomarker for pancreatic cancer.
Transgenomic is a biotech company identifying genetic biomarker using proprietary methods and assays. Transgenomic – genetic biomarker identification Transgenomic is advancing personalized medicine in cardiology, oncology, and inherited diseases through its proprietary molecular technologies. This biotech company is a global … Continue reading → Cet article Transgenomic – g...
Dr H. Jack West discusses one of the hottest topics at ASCO 2015: the evolving role of PD-L1 as an immunotherapy biomarker. Medscape Oncology
Researchers have found a biomarker that appears active in the growth and spread of triple-negative breast cancer. Known as interleukin-13 receptor alpha 2 (IL13Ralpha2), the biomarker may help doctors identify patients at high risk of disease spread ...
SOURCE September 15, 2015 Genfit has boomed in stock market value by 15% since it announced its novel biomarker system for liver disease Non-alcoholic steatohepatitis (NASH). Phase III trials for its drug Elafibranor will incorporate this biomarker system, negating the need for liver biopsies in diagnosis and monitoring of NASH. […]
At last years DigiPharm 2014 event, Debraj Dasgupta , Team Leader – Oncology, Metabolism, Immunology, Boehringer Ingelheim GmbH, gave the presentation “Driving customer centricity at headquarters through ... The post Driving customer centricity at headquarters through defining and driving the right KPIs appeared first on Total Biopharma.
Clinicians at LMU have elucidated a mechanism involved in determining the lifespan of antibody-producing cells, and identified a promising new biomarker for monitoring autoimmune diseases like multiple sclerosis and lupus erythematosus.
Aptagen is a biotech company proposing aptamer products and services as reagents, diagnostic and biomarker discovery tools. Aptamers are used in drug discovery, targeted delivery for therapeutics or bioindustrial applications. Aptagen – aptamer-beacon Aptamers (synthetic antibodies) are ligands of RNA, … Continue reading → Cet article Aptagen – aptamer-beacon est apparu en ...
A new study identified the molecule known as N1,N12-diacetylspermine as a potential biomarker for early-stage non–small-cell lung cancer.
(Pancreatic Cancer Research Fund) A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, UK researchers have found. The discovery could lead to a non-invasive, inexpensive test to screen peo...
Current tests for Alzhemier's disease are costly and inefficient. Scientists may have found a blood biomarker that could be used to test more people who are at-risk of developing the condition.
LOS OSOS, Calif., July 14, 2015 /PRNewswire/ -- Discovery Life Sciences, Inc., a provider of essential clinical research products and services to the Life Sciences industry announced today that it has launched Magellan – an innovative online ordering platform for ready-to-deliver Human Biospecimens designed for Biopharmaceutical, Biotechnology and Medical Device companies who seek ...
* Announces the development of a new reliable and non-invasive diagnostic method, based on the measurement of a novel type of blood biomarker: small non-coding RNA, or miRNA
A much-needed biomarker for head and neck squamous cell carcinoma (HNSCC) that assesses tumor DNA shed in plasma and saliva is in the works. Medscape Medical News
Type: Original PaperIt is often necessary to adjust for detectable endogenous biomarker levels in spiked validation samples (VS) and in selectivity determinations during bioanalytical method validation for ligand-binding assays (LBA) with a matrix li...